Title: Founding Director, Professor
Company: Hansjörg Wyss Institute for Biologically Inspired Engineering at Harvard University
Location: Boston, Massachusetts, United States
Donald E. Ingber, MD, PhD, Founding Director and Professor at the Hansjörg Wyss Institute for Biologically Inspired Engineering at Harvard University, has been recognized by Marquis Who’s Who Top Scientists for dedication, achievements, and leadership in biological engineering and higher education.
Interested in the sciences from a formative age, Dr. Ingber was fascinated by the way cells moved throughout the body. Majoring in science as an undergraduate student, he attended Yale University, where he earned a Bachelor of Arts and Master of Arts in 1977, as well as a Master of Philosophy in 1981. Continuing his studies at the university, he received a Doctor of Medicine and Doctor of Philosophy in 1984. He subsequently served in a fellowship at the Children’s Hospital at Harvard Medical School for the following two years. His first teaching appointment was at Brigham and Women’s Hospital at Harvard Medical School, where he served as an instructor of pathology from 1986 to 1988. Ascending the ranks to assistant professor, associate professor and full professor between 1988 and 2016, he has since become the Judah Folkman Professor of Vascular Biology in the department of surgery at the Children’s Hospital at Harvard Medical School since 2016. In addition to this prominent role, he has been a professor of bioengineering at the Harvard University John A. Paulson School of Engineering and Applies Sciences since 2008 and the director of the Hansjörg Wyss Institute for Biologically Inspired Engineering at Harvard University since 2009. He cites founding the institute as an absolute career highlight.
A frequent consultant in biotechnology in the field, Dr. Ingber current consults for Roche, FreeFlow Medical Devices, Puretech Health LLC, Emulate Incorporated, SynDevRx Incorporated, and Pharmasonics Incorporated. He previously served in the same capacity for numerous other prestigious organizations, such as L’Oreal, AstraZeneca Incorporated, WikiFoods Incorporated, Momenta Pharmaceuticals, Surface Logix Incorporated, ChemGenics Pharmaceuticals, the Merck Corporation, and Digene Diagnostics, among numerous others. The co-founder of Neomorphics in Boston, MA, where he served as a consultant in biotechnology from 1988 to 1992, he holds over 150 patents in the field.
Dr. Ingber has notably contributed over 450 articles to professional journals and helped to found the fields of tumor angiogenesis, mechanobiology and biologically inspired engineering. His patents include organs-on-chips, angiogenesis inhibitors, biomimetic materials, medical devices, filtration systems, computer software and tissue engineering applications. In addition, he was responsible for the development of the concept of a “Tensegrity Model” for cell and tissue architecture and discovered a new class of anti-cancer drugs which inhibit blood vessel growth (angiogenesis), including TNP-470. Impressively, he further demonstrated the importance of extracellular matrix, integrins and mechanical stresses as regulators in tissue development.
In light of his professional accomplishments, Dr. Ingber has accrued a plethora of accolades and honors. Named to the Highly Cited Researchers List by Clarivate Analytics, he also received the Founder’s Award from the Biophysical Society, the Pioneer Award from the University of Pittsburgh, the Max Tischler Lecture Award from Tufts University and the Shu Chien Award from the Biomedical Engineering Society. In previous years, he received the Graeme Clarke Award from the ICT for Life Sciences Forum in Melbourne, Australia, as well as the World’s Most Innovative People Award from the World Summit on Innovation and Entrepreneurship in New York City, the Leading Edge Award from the Society of Toxicology, the Thought Leader Award from Agilent Incorporated, and the Richard M. Bachrach Award from the American Association of Orthopedic Medicine Annual Meeting. He has also been honored multiple times by such prominent entities as the American Thoracic Society, the Society of in Vitro Biology, the Biomedical Engineering Society, the University of Padova in Italy, and the University of Illinois Urbana-Champaign. Earlier in his career, he won the John F. and Virginia B. Taplin Award from the Harvard-Massachusetts Institute of Technology HST Division and several pre- and post-doctoral fellowships.
Married to Ellen Dolnansky, Dr. Ingber is the proud father of one son, Mark. He has been highlighted in the 54th edition of Who’s Who in America, the third edition of Who’s Who in Medicine and Healthcare, the 26th edition of Who’s Who in the East, and several editions of Who’s Who in Science and Engineering and Who’s Who in the World.
For more information, please visit:
Contact Dr. Ingber: